American Gene Technologies International's Unattributed VC Round

American Gene Technologies International raised a round of funding on February 20, 2018. Investors include Alumni Ventures Group.

American Gene Technologies is developing and commercializing genetic medicines targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma (liver cancer, or HCC).…

Articles about American Gene Technologies International's Unattributed VC Round: